Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism

Precigen Inc. (NASDAQ:PGEN) is one of the best multibagger stocks to invest in right now. Among the company’s proprietary therapeutic platforms, its UltraCAR-T platform offers a differentiated approach to CAR-T treatment, aiming for faster manufacturing and potentially improved safety profiles. The company has multiple candidates progressing through clinical trials, which are being used to build a robust pipeline that addresses significant unmet medical needs.

Precigen’s (PGEN) Papzimeos Push Sparks Multibagger Ascent, Boosted by Analyst Optimism

Precigen Inc.’s (NASDAQ:PGEN) stock is up over 300% year-to-date. Its share price has doubled since mid-August after the successful FDA approval of its Papzimeos therapy, which is the first and only approved treatment for adults with recurrent respiratory papillomatosis.

The approval was seen as highly favourable by the street. Following the news, analysts from JPMorgan had upgraded the stock to Neutral from Underweight, citing the removal of a major overhang. Analysts from Cantor Fitzgerald and H.C. Wainwright had also reiterated their Buy ratings.

For H.C. Wainwright’s Swayampakula Ramakanth, the approval came earlier than expected and covers a broad indication in recurrent respiratory papillomatosis, targeting roughly 27,000 U.S. adults. With Q4 2025 sales projected at $15 million and a focused launch strategy, Ramakanth sees meaningful commercial potential despite regulatory and execution risks.

Precigen Inc. (NASDAQ:PGEN) is a biopharmaceutical company that develops gene and cellular therapies, with a focus on immuno-oncology, autoimmune disorders, and infectious diseases.

While we acknowledge the potential of PGEN to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than PGEN and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 10 Most Shorted Stocks Right Now and 10 Best High Beta Stocks To Buy Now.

Disclosure: None. This article is originally published at Insider Monkey.